Advanced in Virilizing Ovarian Tumor

Dr. Linus T. Chuang

Gynecologic Oncology | Oncology
Nuvance Health Medical Practice, PC
672 Stoneleigh Ave, Suite C112, 
Carmel, NY 
Advanced in Virilizing Ovarian Tumor
Nuvance Health Medical Practice, PC
672 Stoneleigh Ave, Suite C112, 
Carmel, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Linus Chuang is a Gynecologic Oncologist and an Oncologist in Carmel, New York. Dr. Chuang is rated as an Advanced provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Endometrial Cancer, Cervical Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Endoscopy.

His clinical research consists of co-authoring 99 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gynecologic Oncology
Oncology
Licenses
Obstetrics & Gynecology in NY
Hospital Affiliations
Putnam Hospital Center
Vassar Brothers Medical Center
Danbury Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

NUVANCE HEALTH MEDICAL PRACTICE, PC
672 Stoneleigh Ave, Suite C112, Carmel, NY 10512
Other Locations
NUVANCE HEALTH MEDICAL PRACTICE CT INC
24 Stevens St, Norwalk, CT 06850

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2025
Intervention Type: Other, Drug, Procedure, Biological
Study Drugs: Carboplatin, Paclitaxel, Pembrolizumab
Study Phase: Phase 3
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
Enrollment Status: Active_not_recruiting
Publish Date: September 16, 2025
Intervention Type: Procedure, Drug, Other
Study Drugs: Cediranib, Cediranib Maleate, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride, Topotecan, Topotecan Hydrochloride
Study Phase: Phase 2/Phase 3
A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 03, 2025
Intervention Type: Other, Procedure, Radiation, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
View 2 Less Clinical Trials

99 Total Publications

Synthesis and Characterization of Poly(Lactic-Co-Glycolic Acid)-Paclitaxel (PLGA-PTX) Nanoparticles Evaluated in Ovarian Cancer Models.
Synthesis and Characterization of Poly(Lactic-Co-Glycolic Acid)-Paclitaxel (PLGA-PTX) Nanoparticles Evaluated in Ovarian Cancer Models.
Journal: Pharmaceutics
Published: March 27, 2025
Similar Doctors
Distinguished in Virilizing Ovarian Tumor
Dr. Dennis S. Chi
Gynecologic Oncology | Oncology | General Surgery
Distinguished in Virilizing Ovarian Tumor
Dr. Dennis S. Chi
Gynecologic Oncology | Oncology | General Surgery

Mskcc Surgery Group

1275 York Ave, 
New York, NY 
 (45.6 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dennis Chi is a Gynecologic Oncologist and an Oncologist in New York, New York. Dr. Chi is rated as an Elite provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Oophorectomy, and Salpingo-Oophorectomy. Dr. Chi is currently accepting new patients.

Distinguished in Virilizing Ovarian Tumor
Dr. Oliver Zivanovic
Gynecologic Oncology | Oncology
Distinguished in Virilizing Ovarian Tumor
Dr. Oliver Zivanovic
Gynecologic Oncology | Oncology
1275 York Ave, 
New York, NY 
 (45.6 miles away)
212-639-7033
Languages Spoken:
English
See accepted insurances

Oliver Zivanovic is a Gynecologic Oncologist and an Oncologist in New York, New York. Dr. Zivanovic is rated as an Elite provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Lymphadenectomy.

Distinguished in Virilizing Ovarian Tumor
Dr. Yukio Sonoda
Gynecologic Oncology | Oncology
Distinguished in Virilizing Ovarian Tumor
Dr. Yukio Sonoda
Gynecologic Oncology | Oncology

Msk Harrison

500 Westchester Ave, 
West Harrison, NY 
 (25.0 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Yukio Sonoda is a Gynecologic Oncologist and an Oncologist in West Harrison, New York. Dr. Sonoda is rated as an Elite provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Hysterectomy, and Lymphadenectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chuang's expertise for a condition
ConditionClose
    View All 17 Advanced Conditions
    View All 19 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile